Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma

References

• Bonomi L. Epidemiology of angle-closure glaucoma. Acta Ophthalmol Scand Suppl 2002;236:11–13
   PubMedGoogle Scholar
• Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol 1989;107:186–188
   PubMed Web of Science ®Google Scholar
• Yücel YH, Zhang Q, Weinreb RN, Kaufman PL, Gupta N. Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma. Prog Retin Eye Res 2003;22:465–481
   PubMed Web of Science ®Google Scholar
• Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 2005;46:175–182
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Maruyama K, Himori N, Omodaka K, Yokoyama Y, Shiga Y, et al. The novel Rho kinase (ROCK) inhibitor K-115: a new candidate drug for neuroprotective treatment in glaucoma. Invest Ophthalmol Vis Sci 2014;55:7126–7136
   PubMed Web of Science ®Google Scholar
• Chidlow G, Wood JP, Casson RJ. Pharmacological neuroprotection for glaucoma. Drugs 2007;67:725–759
   PubMed Web of Science ®Google Scholar
• Miller RG, Mitchell JD, Lyon M, Moore DH. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:191–206
   PubMed Web of Science ®Google Scholar
• Hains BC, Waxman SG. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma. Invest Ophthalmol Vis Sci 2005;46:4164–4169
   PubMed Web of Science ®Google Scholar
• Springer JE, Azbill RD, Kennedy SE, George J, Geddes JW. Rapid calpain I activation and cytoskeletal protein degradation following traumatic spinal cord injury: attenuation with riluzole pretreatment. J Neurochem 1997;69:1592–1600
   PubMed Web of Science ®Google Scholar
• Segal MM, Douglas AF. Late sodium channel openings underlying epileptiform activity are preferentially diminished by the anticonvulsant phenytoin. J Neurophysiol 1997;77:3021–3034
   PubMed Web of Science ®Google Scholar
• Schwartz G, Fehlings MG. Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole. Prog Brain Res 2002;137:177–190
   PubMed Web of Science ®Google Scholar
• Mozaffarieh M, Grieshaber MC, Orgül S, Flammer J. The potential value of natural antioxidative treatment in glaucoma. Surv Ophthalmol 2008;53:479–505
   PubMed Web of Science ®Google Scholar
• de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem Soc Trans 2007;35:1156–1160
   PubMed Web of Science ®Google Scholar
• Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, Sun AY. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 2002;958:439–447
   PubMed Web of Science ®Google Scholar
• Gao D, Zhang X, Jiang X, Peng Y, Huang W, Cheng G, Song L. Resveratrol reduces the elevated level of MMP-9 induced by cerebral ischemia-reperfusion in mice. Life Sci 2006;78:2564–2570
   PubMed Web of Science ®Google Scholar
• Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA. Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 2009;159:993–1002
   PubMed Web of Science ®Google Scholar
• Kiziltepe U, Turan NN, Han U, Ulus AT, Akar F. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 2004;40:138–145
   PubMed Web of Science ®Google Scholar
• Shigematsu S, Ishida S, Hara M, Takahashi N, Yoshimatsu H, Sakata T, et al. Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants. Free Radic Biol Med 2003;34:810–817
   PubMed Web of Science ®Google Scholar
• Birrell MA, McCluskie K, Wong S, Donnelly LE, Barnes PJ, Belvisi MG. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J 2005;19:840–841
   PubMed Web of Science ®Google Scholar
• Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004;430:686–689
   PubMed Web of Science ®Google Scholar
• Chang G, Guo Y, Jia Y, Duan W, Li B, Yu J, Li C. Protective effect of combination of sulforaphane and riluzole on glutamate-mediated excitotoxicity. Biol Pharm Bull 2010;33:1477–1483
   PubMed Web of Science ®Google Scholar
• Siciliano G, Carlesi C, Pasquali L, Piazza S, Pietracupa S, Fornai F, et al. Clinical trials for neuroprotection in ALS. CNS Neurol Disord Drug Targets 2010;9:305–313
   PubMed Web of Science ®Google Scholar
• Mimura T, Kaji Y, Noma H, Funatsu H, Okamoto S. The role of SIRT1 in ocular aging. Exp Eye Res 2013;116:17–26
   PubMed Web of Science ®Google Scholar
• Kim SH, Park JH, Kim YJ, Park KH. The neuroprotective effect of resveratrol on retinal ganglion cells after optic nerve transection. Mol Vis 2013;19:1667–1676
   PubMed Web of Science ®Google Scholar
• Yáñez M, Galán L, Matías-Guiu J, Vela A, Guerrero A, García AG. CSF from amyotrophic lateral sclerosis patients produces glutamate independent death of rat motor brain cortical neurons: protection by resveratrol but not riluzole. Brain Res 2011;1423:77–86
   PubMed Web of Science ®Google Scholar
• Moreno MC, Marcos HJ, Oscar Croxatto J, Sande PH, Campanelli J, Jaliffa CO, et al. A new experimental model of glaucoma in rats through intracameral injections of hyaluronic acid. Exp Eye Res 2005;81:71–80
   PubMed Web of Science ®Google Scholar
• Moore CG, Johnson EC, Morrison JC. Circadian rhythm of intraocular pressure in the rat. Curr Eye Res 1996;15:185–191
   PubMed Web of Science ®Google Scholar
• Drouyer E, Dkhissi-Benyahya O, Chiquet C, WoldeMussie E, Ruiz G, Wheeler LA, et al. Glaucoma alters the circadian timing system. PLoS One 2008;3:e3931
   PubMed Web of Science ®Google Scholar
• Moore CG, Epley D, Milne ST, Morrison JC. Long-term non-invasive measurement of intraocular pressure in the rat eye. Curr Eye Res 1995;14:711–717
   PubMed Web of Science ®Google Scholar
• Moore CG, Milne ST, Morrison JC. Noninvasive measurement of rat intraocular pressure with the Tono-Pen. Invest Ophthalmol Vis Sci 1993;34:363–369
   PubMed Web of Science ®Google Scholar
• Salinas-Navarro M, Jiménez-López M, Valiente-Soriano FJ, Alarcón-Martínez L, Avilés-Trigueros M, Mayor S, et al. Retinal ganglion cell population in adult albino and pigmented mice: a computerized analysis of the entire population and its spatial distribution. Vision Res 2009;49:637–647
   PubMed Web of Science ®Google Scholar
• Salinas-Navarro M, Mayor-Torroglosa S, Jiménez-López M, Avilés-Trigueros M, Holmes TM, Lund RD, et al. A computerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats. Vision Res 2009;49:115–126
   PubMed Web of Science ®Google Scholar
• Sellés-Navarro I, Villegas-Pérez MP, Salvador-Silva M, Ruiz-Gómez JM, Vidal-Sanz M. Retinal ganglion cell death after different transient periods of pressure-induced ischemia and survival intervals. A quantitative in vivo study. Invest Ophthalmol Vis Sci 1996;37:2002–2014
   PubMed Web of Science ®Google Scholar
• WoldeMussie E, Ruiz G, Wijono M, Wheeler LA. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci 2001;42:2849–2855
   PubMed Web of Science ®Google Scholar
• WoldeMussie E, Wijono M, Ruiz G. Muller cell response to laser-induced increase in intraocular pressure in rats. Glia 2004;47:109–119
   PubMed Web of Science ®Google Scholar
• Blair M, Pease ME, Hammond J, Valenta D, Kielczewski J, Levkovitch-Verbin H, Quigley H. Effect of glatiramer acetate on primary and secondary degeneration of retinal ganglion cells in the rat. Invest Ophthalmol Vis Sci 2005;46:884–890
   PubMed Web of Science ®Google Scholar
• Kuehn MH, Fingert JH, Kwon YH. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am 2005;18:383–395
   PubMedGoogle Scholar
• Leikert JF, Räthel TR, Wohlfart P, Cheynier V, Vollmar AM, Dirsch VM. Red wine polyphenols enhance endothelial nitric oxide synthase expression and subsequent nitric oxide release from endothelial cells. Circulation 2002;106:1614–1617
   PubMed Web of Science ®Google Scholar
• Fuhrman B, Volkova N, Coleman R, Aviram M. Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E deficient (E0) mice and reduce macrophage atherogenicity. J Nutr 2005;135:722–728
   PubMed Web of Science ®Google Scholar
• Garvin S, Ollinger K, Dabrosin C. Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 2006;231:113–122
   PubMed Web of Science ®Google Scholar
• Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 1996;20:933–956
   PubMed Web of Science ®Google Scholar
• Saito S, Ohashi M, Naito A, Fukaya Y, Suzuki Y, Araie M. Neuroprotective effect of the novel Na+/Ca2+ channel blocker NS-7 on rat retinal ganglion cells. Jpn J Ophthalmol 2005;49:371–376
   PubMed Web of Science ®Google Scholar
• Lagreze WA, Knorle R, Bach M, Feuerstein TJ. Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci 1998;39:1063–1066
   PubMed Web of Science ®Google Scholar
• Toriu N, Akaike A, Yasuyoshi H, Zhang S, Kashii S, Honda Y, et al. Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp Eye Res 2000;70:475–484
   PubMed Web of Science ®Google Scholar
• Choi DW. Ionic dependence of glutamate neurotoxicity. J Neurosci 1987;7:369–379
   PubMed Web of Science ®Google Scholar
• Hubert JP, Delumeau JC, Glowinski J, Prémont J, Doble A. Antagonism by riluzole of entry of calcium evoked by NMDA and veratridine in rat cultured granule cells: evidence for a dual mechanism of action. Br J Pharmacol 1994;113:261–267
   PubMed Web of Science ®Google Scholar
• Malgouris C, Daniel M, Doble A. Neuroprotective effects of riluzole on N-methyl-d-aspartate- or veratridine-induced neurotoxicity in rat hippocampal slices. Neurosci Lett 1994;177:95–99
   PubMed Web of Science ®Google Scholar
• Vorwerk CK, Zurakowski D, McDermott LM, Mawrin C, Dreyer EB. Effects of axonal injury on ganglion cell survival and glutamate homeostasis. Brain Res Bull 2004;62:485–490
   PubMed Web of Science ®Google Scholar
• Ettaiche M, Fillacier K, Widmann C, Heurteaux C, Lazdunski M. Riluzole improves functional recovery after ischemia in the rat retina. Invest Ophthalmol Vis Sci 1999;40:729–736
   PubMed Web of Science ®Google Scholar
• Nikolaeva MA, Mukherjee B, Stys PK. Na+-dependent sources of intra-axonal Ca2+ release in rat optic nerve during in vitro chemical ischemia. J Neurosci 2005;25:9960–9967
   PubMed Web of Science ®Google Scholar
• Stys PK. General mechanisms of axonal damage and its prevention. J Neurol Sci 2005;233:3–13
   PubMed Web of Science ®Google Scholar
• Sandalon S, Könnecke B, Levkovitch-Verbin H, Simons M, Hein K, Sättler MB, et al. Functional and structural evaluation of lamotrigine treatment in rat models of acute and chronic ocular hypertension. Exp Eye Res 2013;115:47–56
   PubMed Web of Science ®Google Scholar
• Wu Y, Satkunendrarajah K, Teng Y, Chow DS, Buttigieg J, Fehlings MG. Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. J Neurotrauma 2013;15;30:441–452
   PubMed Web of Science ®Google Scholar
• Mu X, Azbill RD, Springer JE. Riluzole improves measures of oxidative stress following traumatic spinal cord injury. Brain Res 2000;870:66–72
   PubMed Web of Science ®Google Scholar
• Liu XQ, Wu BJ, Pan WH, Zhang XM, Liu JH, Chen MM, et al. Resveratrol mitigates rat retinal ischemic injury: the roles of matrix metalloproteinase-9, inducible nitric oxide, and heme oxygenase-1. J Ocul Pharmacol Ther 2013;29:33–40
   PubMed Web of Science ®Google Scholar
• Luna C, Li G, Liton PB, Qiu J, Epstein DL, Challa P, Gonzalez P. Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol 2009;47:198–204
   PubMed Web of Science ®Google Scholar
• Heurteaux C, Laigle C, Blondeau N, Jarretou G, Lazdunski M. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. Neuroscience 2006;137:241–251
   PubMed Web of Science ®Google Scholar
• Dong W, Li N, Gao D, Zhen H, Zhang X, Li F. Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angiogenic factors. J Vasc Surg 2008;48:709--714
   Google Scholar
• Schwartz GW, Fehlings MG. Evaluation of the neuroprotective effects of sodium channel blockers after spinal cord injury: improved behavioral and neuroanatomical recovery with riluzole. J Neurosurg 2001;94:245–256
   PubMed Web of Science ®Google Scholar
• Ates O, Cayli SR, Gurses I, Turkoz Y, Tarim O, Cakir CO, Kocak A. Comparative neuroprotective effect of sodium channel blokers after experimental spinal cord injury. J Clin Neurosci 2007;14:658–665
   PubMed Web of Science ®Google Scholar
• Morris-Blanco KC, Cohan CH, Neumann JT, Sick TJ, Perez-Pinzon MA. Protein kinase C epsilon regulates mitochondrial pools of Nampt and NAD following resveratrol and ischemic preconditioning in the rat cortex. J Cereb Blood Flow Metab 2014;34:1024--1032
   Google Scholar
• Benazzouz A, Boraud T, Dubédat P, Boireau A, Stutzmann JM, Gross C. Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study. Eur J Pharmacol 1995;284:299–307
   PubMed Web of Science ®Google Scholar
• Medico M, Nicosia A, Grech M, Onesta M, Sessa G, Rampello L, et al. Riluzole restores motor activity in rats with post-traumatic peripheral neuropathy. Neurosci Lett 2004;358:37–40
   PubMed Web of Science ®Google Scholar
• Ruel J, Wang J, Pujol R, Hameg A, Dib M, Puel JL. Neuroprotective effect of riluzole in acute noise-induced hearing loss. Neuroreport 2005;16:1087–1090
   PubMed Web of Science ®Google Scholar
• Abdul Y, Akhter N, Husain S. Delta-opioid agonist SNC-121 protects retinal ganglion cell function in a chronic ocular hypertensive rat model. Invest Ophthalmol Vis Sci 2013;54:1816–1828
   PubMed Web of Science ®Google Scholar